|
BRD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.337800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.915200E-01 |
| Normal-vs-Stage2 |
1.250030E-01 |
| Normal-vs-Stage3 |
8.061300E-03 |
| Normal-vs-Stage4 |
8.672300E-02 |
| Stage1-vs-Stage2 |
2.514000E-01 |
| Stage1-vs-Stage3 |
2.050200E-02 |
| Stage1-vs-Stage4 |
2.285400E-01 |
| Stage2-vs-Stage3 |
6.418600E-01 |
| Stage2-vs-Stage4 |
9.216200E-01 |
| Stage3-vs-Stage4 |
5.036000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.093800E-02 |
| Normal-vs-AfricanAmerican |
3.752600E-01 |
| Normal-vs-Asian |
2.773000E-01 |
| Caucasian-vs-AfricanAmerican |
6.608200E-01 |
| Caucasian-vs-Asian |
1.114360E-01 |
| AfricanAmerican-vs-Asian |
2.392600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.855600E-03 |
| Normal-vs-Female |
8.111000E-01 |
| Male-vs-Female |
2.535300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.618800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.594400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.926210E-02 |
| Normal-vs-Age(81-100Yrs) |
3.915200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.341600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.904000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.663780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.737500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.597900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.317200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.321600E-03 |
| Normal-vs-Grade 2 |
2.440800E-01 |
| Normal-vs-Grade 3 |
8.638300E-03 |
| Normal-vs-Grade 4 |
9.915800E-02 |
| Grade 1-vs-Grade 2 |
4.583200E-03 |
| Grade 1-vs-Grade 3 |
1.621620E-04 |
| Grade 1-vs-Grade 4 |
1.480730E-03 |
| Grade 2-vs-Grade 3 |
3.966400E-02 |
| Grade 2-vs-Grade 4 |
4.081000E-01 |
| Grade 3-vs-Grade 4 |
5.123800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.788810E-01 |
| Normal-vs-ccB subtype |
1.296020E-01 |
| ccA subtype-vs-ccB subtype |
8.331400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.549600E-02 |
| Normal-vs-N1 |
8.179000E-01 |
| N0-vs-N1 |
5.153000E-01 |
|
|
